Aliskiren/valsartan combination for the treatment of cardiovascular and renal diseases

SA Yarows - Expert Review of Cardiovascular Therapy, 2010 - Taylor & Francis
Chronic activation of the renin–angiotensin–aldosterone system (RAAS) plays a key role in
the development of hypertension, and cardiac and renal diseases. RAAS inhibitors, such as …
被引用次数：22 相关文章

Aliskiren/valsartan combination for the treatment of cardiovascular and renal diseases.

SA Yarows - Expert Review of Cardiovascular Therapy, 2010 - europepmc.org
Aliskiren/valsartan combination for the treatment of cardiovascular and renal diseases. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

Aliskiren/valsartan combination for the treatment of cardiovascular and renal diseases

SA Yarows - Expert review of cardiovascular therapy, 2010 - pubmed.ncbi.nlm.nih.gov
Chronic activation of the renin-angiotensin-aldosterone system (RAAS) plays a key role in
the development of hypertension, and cardiac and renal diseases. RAAS inhibitors, such as …

[引用][C] Aliskiren/valsartan combination for the treatment of cardiovascular and renal diseases

SA YAROWS - Expert Rev Cardiovasc Ther., 2010 - cir.nii.ac.jp

Aliskiren/valsartan combination for the treatment of cardiovascular and renal diseases

SA Yarows - Expert Review of Cardiovascular Therapy, 2010 - search.proquest.com
Chronic activation of the renin--angiotensin--aldosterone system (RAAS) plays a key role in
the development of hypertension, and cardiac and renal diseases. RAAS inhibitors, such as …

Aliskiren/valsartan combination for the treatment of cardiovascular and renal diseases

SA Yarows - Expert Review of Cardiovascular Therapy, 2010 - go.gale.com
The renin-angiotensin-aldosterone system (RAAS) plays an important role in the regulation
of blood pressure (BP) and bodily fluid volume, as well as cardiovascular and renal function …